Brandon Folkes Stock Analyst Profile - HC Wainwright & Co. Research Coverage - Stocknear

Brandon Folkes

Stock Analyst at HC Wainwright & Co.

(3.7)
# 2474
Out of 5,474 analysts
100
Total ratings
Success rate
Average return
43 Stocks
Name Action PT Current % Upside Ratings Updated
MNKD MannKind
Maintains: Strong Buy
9 11
5.51 99.64% 4 Sep 2, 2025
VALN Valneva
Reiterates: Buy
18 18
8.93 101.57% 2 Aug 25, 2025
DERM Journey Medical
Initiates Coverage On: Buy
13
7.45 74.5% 2 Aug 25, 2025
ACHV Achieve Life Science...
Initiates Coverage On: Buy
12
3.12 284.62% 2 Aug 21, 2025
EPRX Eupraxia Pharmaceuti...
Reiterates: Buy
12 12
5.26 128.14% 3 Aug 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
9
4.01 124.44% 1 Aug 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
13 13
3.49 272.49% 4 Aug 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
1.76 297.73% 2 Aug 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
10
7.68 30.21% 1 Aug 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
44
37.97 15.88% 6 Aug 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
84 93
98.46 -5.55% 5 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 17
13.03 30.47% 3 Aug 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
29
6.89 320.9% 1 Aug 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
28
24.66 13.54% 1 Aug 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
20
9.04 121.24% 1 Jul 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
26
8.21 216.69% 1 Jul 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
1.3 361.54% 2 Jun 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
5
1.72 190.7% 2 Jun 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
1.03 773.79% 1 Jun 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
21
8.42 149.41% 2 May 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
5
1.8 177.78% 1 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
4.26 111.27% 2 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
n/a n/a 1 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
16 16
8.26 93.7% 6 Sep 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
n/a n/a 2 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
455
25.13 1710.58% 1 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
59
34.39 71.56% 4 Sep 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
8
1.49 436.91% 4 Sep 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
180
128.53 40.05% 2 Aug 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 15
14.7 0.34% 2 Jan 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
300 220
3.47 6240.06% 3 Dec 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
5
n/a n/a 1 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
6
n/a n/a 1 Jun 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
28 32
27.85 14.9% 3 Jan 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
40
0.82 4778.05% 1 Sep 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
22000
n/a n/a 1 Aug 31, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
3125
n/a n/a 1 Aug 28, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
38 53
n/a n/a 4 Aug 20, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
405 315
9.6 3181.25% 3 Mar 5, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
58 46
n/a n/a 6 Mar 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
32 42
20.65 103.39% 2 Sep 28, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
42 50
14.49 245.07% 1 Jul 12, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
7 4
n/a n/a 2 Mar 13, 2018